AKTS Smart Money
Aktis Oncology, Inc.
1W: -4.7%
1M: -31.2%
3M: -30.3%
YTD: -17.3%
1Y: +18875.4%
3Y: +401.9%
5Y: +145.6%
$18.52
+0.00 (+0.00%)
Weekly Expected Move ±7.5%
$16
$17
$19
$20
$21
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q2 2026122
Institutions Holding
+53 vs prior
102.7%
Ownership
+46.60%
55
New
28
Increased
23
Reduced
6
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-23 | Czibere Akos | officer: chief medical officer | S-Sale | 7,401 | $21.03 | $156K | Filing |
| 2026-09-23 | Czibere Akos | officer: chief medical officer | S-Sale | 5,099 | $20.19 | $103K | Filing |
| 2026-07-20 | Herrmann Ken | director | S-Sale | 1,350 | $24.56 | $33K | Filing |
| 2026-07-20 | Herrmann Ken | director | S-Sale | 3,506 | $24.56 | $86K | Filing |
| 2026-07-17 | Herrmann Ken | director | S-Sale | 3,065 | $25.21 | $77K | Filing |
| 2026-07-08 | Czibere Akos | officer: chief medical officer | S-Sale | 4,371 | $28.71 | $125K | Filing |
| 2026-07-08 | Czibere Akos | officer: chief medical officer | S-Sale | 30,829 | $27.95 | $862K | Filing |
| 2026-07-08 | Czibere Akos | officer: chief medical officer | S-Sale | 14,800 | $27.13 | $401K | Filing |
| 2026-07-08 | Ron-Bigger Shulamit | officer: chief operating officer | S-Sale | 4,200 | $28.75 | $121K | Filing |
| 2026-07-08 | Ron-Bigger Shulamit | officer: chief operating officer | S-Sale | 30,000 | $27.94 | $838K | Filing |
| 2026-07-08 | Ron-Bigger Shulamit | officer: chief operating officer | S-Sale | 15,800 | $27.13 | $429K | Filing |
| 2026-01-12 | Vida Ventures II, LLC | 10% owner | P-Purchase | 22,545 | $18.00 | $406K | Filing |
| 2026-01-12 | VIDA VENTURES II-A, LLC | 10% owner | C-Conversion | 134,842 | $— | $0 | Filing |
| 2026-01-12 | VIDA VENTURES II-A, LLC | 10% owner | P-Purchase | 22,545 | $18.00 | $406K | Filing |
| 2026-01-12 | Vida Ventures II, LLC | 10% owner | C-Conversion | 134,842 | $— | $0 | Filing |
| 2026-01-12 | VIDA VENTURES II-A, LLC | 10% owner | P-Purchase | 812,455 | $18.00 | $14.6M | Filing |
| 2026-01-12 | Vida Ventures II, LLC | 10% owner | P-Purchase | 812,455 | $18.00 | $14.6M | Filing |
| 2026-01-12 | VIDA VENTURES II-A, LLC | 10% owner | C-Conversion | 4,859,370 | $— | $0 | Filing |
| 2026-01-12 | Vida Ventures II, LLC | 10% owner | C-Conversion | 4,859,370 | $— | $0 | Filing |
| 2026-01-12 | Kim Helen Susan | director | C-Conversion | 4,859,370 | $— | $0 | Filing |
| 2026-01-12 | NODELMAN OLEG | director | P-Purchase | 144,443 | $18.00 | $2.6M | Filing |
| 2026-01-12 | EcoR1 Capital, LLC | director | P-Purchase | 144,443 | $18.00 | $2.6M | Filing |
| 2026-01-12 | NODELMAN OLEG | director | P-Purchase | 2,077,779 | $18.00 | $37.4M | Filing |
| 2026-01-12 | EcoR1 Capital, LLC | director | C-Conversion | 128,506 | $— | $0 | Filing |
| 2026-01-12 | NODELMAN OLEG | director | C-Conversion | 202,862 | $— | $0 | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| MPM BIOIMPACT LLC | 4,835,872 | $156M | — | 2026-06-30 | Filing |
| EcoR1 Capital, LLC | 4,824,469 | $155M | — | 2026-06-30 | Filing |
| Blue Owl Capital Holdings LP | 3,070,219 | $99M | -91,129 | 2026-06-30 | Filing |
| BlackRock, Inc. | 2,278,358 | $73M | +166,231 | 2026-06-30 | Filing |
| WELLINGTON MANAGEMENT GROUP LLP | 1,966,244 | $63M | -350,800 | 2026-06-30 | Filing |
| RTW INVESTMENTS, LP | 1,592,043 | $51M | — | 2026-06-30 | Filing |
| RA CAPITAL MANAGEMENT, L.P. | 1,314,405 | $42M | -188,679 | 2026-06-30 | Filing |
| Jupiter Topco LLC | 1,314,267 | $42M | +1,314,267 | 2026-06-30 | Filing |
| BAKER BROS. ADVISORS LP | 996,351 | $32M | — | 2026-06-30 | Filing |
| Octagon Capital Advisors LP | 960,847 | $31M | — | 2026-06-30 | Filing |
| Merck & Co., Inc. | 952,844 | $31M | — | 2026-06-30 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 817,075 | $26M | -16,838 | 2026-06-30 | Filing |
| TCG Crossover Management, LLC | 696,560 | $22M | +696,560 | 2026-06-30 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 520,737 | $17M | +28,801 | 2026-06-30 | Filing |
| EVENTIDE ASSET MANAGEMENT, LLC | 507,000 | $16M | — | 2026-06-30 | Filing |
| Avidity Partners Management LP | 484,200 | $16M | +15,634 | 2026-06-30 | Filing |
| STATE STREET CORP | 484,010 | $16M | +55,757 | 2026-06-30 | Filing |
| a16z Capital Management, L.L.C. | 415,000 | $13M | — | 2026-06-30 | Filing |
| Alyeska Investment Group, L.P. | 290,000 | $9M | — | 2026-06-30 | Filing |
| FMR LLC | 285,631 | $9M | -100,748 | 2026-06-30 | Filing |